Reordering the pecking order: management describes the company winning on a stage where it used to be too small to play
The model's full reasoning — Q3 2021 call → NOWe need to answer YES or NO based on the transcript. The question asks: does management describe that the company is NOW COMPETING AND WINNING AT A LEVEL OF THE MARKET THAT USED TO BE ABOVE IT — that is, does management convey that the company has recently begun to be treated as a legitimate contender in situations, against rivals, or for business that previously would have gone to bigger, more established, or more entrenched players, and that this has already produced real results in the current period? We need to look for evidence in the transcript. The company is LeMaitre Vascular, a medical device company. They talk about sales force expansion, Artegraft acquisition, etc. But the question is about moving up a tier in the market. Let's scan the transcript. Management discusses: sales growth, Delta variant, hiring sales reps, Artegraft performance, pricing, etc. They mention that Artegraft is going well, they are increasing prices, and they are competing. But is there any mention of moving up a tier? For example, being considered for larger deals, displacing incumbents, being admitted to a roster, etc. The transcript mentions: "We are growing our sales force, maintaining high op margins, generating cash and investing in acquisitions." That's not about tier. They talk about Artegraft: "Artegraft is going very well... when we acquired it, about 16 months ago, the sales at the hospital level were $18.6 million. And now if you just take Q3 and annualized that it's running in the $25 million to $26 million range, it's definitely going ahead of the board model, the Q3 sales were up 15%." That's about growth, not necessarily moving up a tier. They talk about price increases: "we put a nice healthy 20% plus price like in Artegraft this year." That's about pricing power. They talk about competing with synthetic grafts: "the number one competitor is a synthetic piece of PTFE, with heparin bonded to it, which was selling for a much higher price. And really didn't have the features and benefits and patency of Artegraft. And so that gave us the confidence to put the price increase." That suggests they are competing with a more established product, but is that a tier change? They are already in the market. They are not saying they are now being considered for business that previously went to bigger players. They are just saying they have a better product.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| SANG | Sangoma Technologies Corporation | Q2 2024 | 2024-02-08 | D |
| PFIE | Profire Energy, Inc. | Q1 2023 | 2023-05-13 | B |
| WD | Walker & Dunlop, Inc. | Q2 2022 | 2022-08-09 | C+ |
| PRIM | Primoris Services Corporation | Q2 2018 | 2018-08-11 | C+ |
PRIM · Q2 2018 → YESThe question is: Does management describe that the company is NOW COMPETING AND WINNING AT A LEVEL OF THE MARKET THAT USED TO BE ABOVE IT? YES The transcript shows management describing exactly this tier shift in the T&D segment: after the Willbros acquisition, the group “has been able to sign new awards with customers that have been hesitant because of previous concerns about their financial viability” and has received work from “some of the largest electrical utilities in the country.” David King notes that the work “outpaces anything he has seen in his 40-plus years,” and Pete Moerbeek adds that the one-year MSA revenue alone is now $1.1 million. Management presents these wins as a direct result of Primoris’s financial strength and parent-company backing, which previously excluded the T&D business from the largest accounts. The commentary frames the development as newly enabled and still early (only one month of T&D performance), satisfying all three required elements: a clear change in competitive tier, real business already won, and contribution still incremental relative to the company’s prior scale.
SANG · Q2 2024 → YESThe question is: Does management describe that the company is NOW COMPETING AND WINNING AT A LEVEL OF THE MARKET THAT USED TO BE ABOVE IT? YES The transcript shows management describing a shift to competing at a higher tier with sophisticated mid-market clients through bundled offerings, illustrated by a recent win with a statewide park department that larger vendors couldn't serve affordably. They explicitly note this represents a change in tier ("the type of client the bundled capabilities of Sangoma can reach ... Sangoma is well positioned to play in both the small market and more sophisticated mid-market") and that it has already produced real results ("this recent win"), while conveying it is early ("there'll be a lag before it delivers material results.
WD · Q2 2022 → YESThe question is: Does management describe that the company is NOW COMPETING AND WINNING AT A LEVEL OF THE MARKET THAT USED TO BE ABOVE IT? YES The transcript shows management explicitly describing a tier shift: from competing "predominantly with the likes of JPMorgan and Wells Fargo" to "going head-to-head with CBRE and JLL," enabled by technology investments that now allow them to "successfully compete against these much larger firms.